DIN 02501244 — ENERZAIR BREEZHALER 160 MCG; 50 MCG; 150 MCG
ENERZAIR BREEZHALER is a capsule of Indacaterol / Glycopyrronium / Mometasone Furoate marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Indacaterol / Glycopyrronium / Mometasone Furoate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02501244
- Brand name
- ENERZAIR BREEZHALER
- Active ingredient
- Indacaterol / Glycopyrronium / Mometasone Furoate
- Strength
- 160 MCG; 50 MCG; 150 MCG
- Dosage form
- CAPSULE
- Route
- INHALATION
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Triple combination bronchodilator/inhaled corticosteroid (LABA/LAMA/ICS) for asthma
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.